<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">159</article-id><article-id pub-id-type="doi">10.36691/RJA159</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">What is аsthma-COPD Overlap syndrome (ACOS), diagnostics and treatment</article-title><trans-title-group xml:lang="ru"><trans-title>Что такое Overlap синдром (ACOS), диагностика и лечение</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fedoseev</surname><given-names>G B</given-names></name><name xml:lang="ru"><surname>Федосеев</surname><given-names>Г Б</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра госпитальной терапии им. акад. М.В. Черноруцкого, доктор медицинских наук, профессор, член-корр. РАН, з.д.н. России.</p></bio><email>fedoseevsp@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Trofimov</surname><given-names>V I</given-names></name><name xml:lang="ru"><surname>Трофимов</surname><given-names>В И</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, зав. кафедрой госпитальной терапии им. акад. М.В. Черноруцкого.</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Negrutsa</surname><given-names>K V</given-names></name><name xml:lang="ru"><surname>Негруца</surname><given-names>К В</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра госпитальной терапии им. акад. М.В. Черноруцкого, аспирант.</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Timchik</surname><given-names>V G</given-names></name><name xml:lang="ru"><surname>Тимчик</surname><given-names>В Г</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, врач функциональной диагностики отделения функциональной диагностики № 2 научно-клинического исследовательского центра.</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Golubeva</surname><given-names>V I</given-names></name><name xml:lang="ru"><surname>Голубева</surname><given-names>В И</given-names></name></name-alternatives><bio xml:lang="ru"><p>биолог лаборатории клинической иммунологии и молекулярной диагностики.</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aleksandrin</surname><given-names>V A</given-names></name><name xml:lang="ru"><surname>Александрин</surname><given-names>В А</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры госпитальной терапии им. акад. М.В. Черноруцкого.</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Razumovskaya</surname><given-names>T S</given-names></name><name xml:lang="ru"><surname>Разумовская</surname><given-names>Т С</given-names></name></name-alternatives><bio xml:lang="ru"><p>ведущий инженер отделения функциональной диагностики № 2 научно-клинического исследовательского центра.</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rabik</surname><given-names>U D</given-names></name><name xml:lang="ru"><surname>Рабик</surname><given-names>Ю Д</given-names></name></name-alternatives><bio xml:lang="ru"><p>зав. отделением функциональной диагностики № 2 научно-клинического исследовательского центра.</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kryakunov</surname><given-names>K N</given-names></name><name xml:lang="ru"><surname>Крякунов</surname><given-names>К Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры госпитальной терапии им. акад. М.В. Черноруцкого.</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Pavlov First Saint Petersburg State Medical University</institution></aff><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2018</year></pub-date><volume>15</volume><issue>2</issue><issue-title xml:lang="en">VOL 15, NO2 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 15, №2 (2018)</issue-title><fpage>17</fpage><lpage>28</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Фармарус Принт Медиа</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2020-12-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/159">https://rusalljournal.ru/raj/article/view/159</self-uri><abstract xml:lang="en"><p>175 patients were examined: 78 patients with bronchial asthma (BA), 39 with Asthma-COPD Overlap Syndrome (ACOS), 38 with chronic obstructive pulmonary disease (COPD) and 20 healthy individuals. A general clinical and laboratory examination was conducted, α1-antitrypsin (AAT), IgG and IgA to four bacterial antigens were determined, and pulmonary function test was studied. The clinical and spirometry data (characterizing the ACOS) were received. Negative association of AAT with respiratory function parameters in patients with ACOS, high levels of IgG antibodies to bacterial antigens and the lack of these connections in patients with BA and COPD allows us to consider ACOS to be independent nosological form related with microbial inflammation and marked by the AAT.</p></abstract><trans-abstract xml:lang="ru"><p>Обследованы 175 человек: 78 пациентов с бронхиальной астмой (БА), 39 - Asthma-COPD Overlap Syndrome (ACOS), 38 - хронической обструктивной болезнью легких (ХОБЛ), 20 практически здоровых. Проводилось общее клиническое и лабораторное обследование, определялись α1-антитрипсин (ААТ), IgG и IgE к четырем бактериальным антигенам, исследовалась ФВД. Получены соответствующие литературным, характеризующие ACOS, клинические и ФВД данные. Наличие у больных ACOS достоверной отрицательной связи ААТ с показателями ФВД и высоких уровней IgG к бактериальным антигенам и отсутствие этих связей у больных БА и ХОБЛ позволяет считать ACOS самостоятельной, отличной от БА и ХОБЛ, связанной с микробным воспалением и маркируемой ААТ нозологической формой.</p></trans-abstract><kwd-group xml:lang="en"><kwd>ACOS</kwd><kwd>bronchial asthma (BA)</kwd><kwd>chronic obstructive pulmonary disease (COPD)</kwd><kwd>ACOS</kwd><kwd>allergy</kwd><kwd>α-antitrypsin (AAT)</kwd><kwd>pulmonary function test</kwd><kwd>inflammation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>бронхиальная астма (БА)</kwd><kwd>хроническая обструктивная болезнь легких (ХОБЛ)</kwd><kwd>аллергия</kwd><kwd>α-антитрипсин (ААТ)</kwd><kwd>функция внешнего дыхания (ФВД)</kwd><kwd>воспаление</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Guerra S. Overlap of asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2005; 11: p. 7-3.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009; 64: 728-735.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>GINA and GOLD. Diagnosis of diseases of chronic airflow limitation: asthma, COPD and ashma-COPD overlap syndrome (ACOS). [updated 2015] Available from: http//www.ginasthma.org.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Cosio BG, Soriano JB, Lopez-Campos JL, Calle-Rubio M, Soler-Cataluna JJ, de-Torres JP et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016; 149: 45-52.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med. 2015; 21: 74-79.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Rogliani P, Ora I, Puxeddu E, Cazzola M. Airflow obstruction: is it asthma or is it COPD? Int J COPD. 2016; 11: 3007-3013.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax. 2015; 70: 683-691.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD overlap syndrome (ACOS). A systematic review and meta analys. PLoS One. 2015; 10: e0136065.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Mirabelli MC, Beavers SF, Chatterjee AB. Active asthma and the prevalence of physician-diagnosed COPD. Lung. 2014; 192: 693-700.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>De Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M et al. The coexistence of asthma and chronic odstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population, PLoS One 8: e62985 [Crossref].</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Miravitlles M, Huerta A, Fernandez-Villar JA, Alcazar B, Villa G, Forne C et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes 12: 20 [Crossref].</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Kauppi P, Kuppi P, Kupiainen H, Lindqvist A, Kilpeläinen M, Kinnula VL et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011; 48: 279-285.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Fu JJ, Gibson PG, Simpson JL, McDonald VM. Longitudinal changes in clinical outcomes in older patient with asthma, COPD and asthma-COPD overlap syndrome. Respiration. 2014; 87: 63-74.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Milanese M, DiMarco F, Corsico AG, Rolla G, Sposato B, Chieco-Bianchi F et al. Asthma control in elderly asthmatics. An Italian observational study. Respir Med. 2014; 108: 1091-1099.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Marsh SE, Travels J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM et al. Proportional classifications of COPD phenotypes. Thorax. 2008; 63: 761-767.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Barnes PJ. Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. Am J Respir Crit Care. Med. 2006; 174: 240-244.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Yayan J, Rasche K. Asthma and COPD: similarities and differences in the pathophysiology, diagnosis and therapy. Adv Exp Med Biol. 2016; 910: 31-38.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Global Initiative for Asthma. Global strategy for asthma management and prevention (updated 2015) (http//www.ginasthma.org/local/uploads/files/GINAReport2015May19.pdf).</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2015) (http: www.goldcopd.org/uploads/users/files/GOLDReport2015Apr2.pdf).</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Postma Ds, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med. 2015; 373: 1241-1249.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Bobolea I., Perez de Liano. Asthma-COPD overlap syndrome (ACOS). Current understanding and future perspectives. Asthma - from childhood asthma to ACOS phenotypes. 2016. (ISBN 978-953-51-2442-9, DOI 10,5772/62412).</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Cosentino J., Zhao H., Hardin M., Hersh CР, Crapo J., Kim V. et al. Analysis of asthma-COPD overlap syndrome when defined on the basis of bronchodilator response and degree of emphysema. Ann Am Thorac Soc. 2016; 13: 1483-1489.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Cazzola M., Rogliani P. Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome? J. Allergy Clin Immonol. 2016; 138: 977-983.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Nakawah MO, Hawkins C., Barbandi F. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J. Amer Board Fam Med. 2013; 26: 470-477.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Soler X., Ramvsdel JW. A asthma and COPD a continuum of the same disease? J. Allergy Clin Immunol Pract. 2015; 3: 489-495.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Orie NGM. The Dutch hypothesis. Chest. 2000; 117: 299.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Don D. Sin. Asthma-COPD overlap syndrome: what we know and what we don’t. Tuberc Respir Dis. 2017; 80: 11-20.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Konstantellou E., Papaioannou AI, loukides S., Patentalakis G., Papaporfyriou A., Hillas G. et al. Persistent airflow obstruction in patients with asthma: characteristics of a distinct clinical phenotype. Respir Med. 2015; 109: 1404-1409.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Menezes AM, Montes de Oca M., Perez-Padilla R., Nadeau G., Wehrmeister FC, Lopez-Varela MV et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014; 145: 297-304.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Ghebre MA, Bafadrel M., Desal D., Ohen SE, Newbold P., Rapley L. et al. Biological clustering supports both «Dutch» and «British» hypotheses of asthma and chronic obstructive pulmonary disease. J. Allergy Clin Immunol. 2015; 135: 63-72.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Koatikas K., Clemens A., Panalano F. The asthma-COPD overlap syndrome: do we really need another syndrome in the altearady complex matrix of airway disease? 2016. DOI: org/10.20147/COPD.S. 107307.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Hardin M., Cho M., McDonaid ML. The clinkal and genetic features of CODP-asthma overlap syndrome. Eur Respir J. 2014; 44: 341-350.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Barrecheguren M., Esquinas C., Miravitlles M. The asth-ma-COPD overlap syndrome: a new entity? COPD Research and Practice. 2015; 1: 8. DOI: 10,1186/s. 40749-015-0012z.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Gonzales-Aguirre JE, Mercado-Longorio R. Asthma-COPD overlap syndrome: A work in progress. 2017, OAT, DOI: 10,15761\PCCM. 10001132.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>National Asthma Council (Australia). Australian Asthma Management Handbook. 2014. A available from: http://www. nationalasthma.org.au/handbook. Accessed February 5, 2016.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Guidelines for the Diagnosis and Treatment of COPD. 3rd Edition. Available from: http//www.jrs.or.jp/uploads/uploads/files/photos/765.pdf2010.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Soler-Cataluna JJ, Cosio B., Izquiero JL, López-Campos JL, Marin JM, Agüero R. et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012; 48: 331-337.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Koblizek V., Chlumsky J., Zindr V., Neumannova K., Zatloukal J., Zak J. et al. Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumolog-ical and Phthisiological Society, a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013; 157(2): 187-201.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Rhee CK. Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome. Korean J. Intern Med. 2015; 30: 443-449.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Iwamoto H., Goac J., Koskela J., Kinnula V., Kobayashi H., Laitinen T. et al. Differences in plasma and sputum biomarkers between COPD and COPD-astma overlap. Eur Respir J. 2014; 43: 421-429.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Chung WS, Lin CL, Kao CL. Comparison acute respiratory events between asthma-COPD patients a population-based cohort study. Medicine (Baltimore). 2015; 94: e755.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Barrecheguren M., Esquinas C., Muravitlles M. The asth-ma-COPD overlap syndrome: a now entity? COPD Research and Practice. 2015; 1: 8. DOI: 10,1186/s. 40749-015-0012z.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Corlateanu A., Covantev S., Matyioudakis AG, Victor Botnaru, Nikolaos Siafakas. Asthma-Cronic obstructive pulmonary disease overlap syndrome (ACOS): current evidence and future research directions. COPD Research Practict. 2017; 3: 6. DOI: 10,1186/s40749-017-0025-x.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Kumbhare S., Pleasats R., Ohar JA, Strange C. Characteristics and prevalence of asthma/COPD overlap in the United States. Proc Am Thorac Soc. 2016; 13: 803-810.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Hazawa N. Clinical approaches towards ashma and chronic obstructive pulmonary disease based on the heterogeneity of disease pathogenesis. Clin Exp Allergy. 2016; 46: 678-687.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Koltsida O., Kousoukou A., Koulouris NG, Rovina N. Asthma-chronic obstructive pulmonary disease overlap syndrome: A diagnostic puzzle for the clinicians. Wold J. Respirol. 2016; 62: 54-56.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Kostikas K., Clements A., Patalano F. The asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease? 2016. DOI: org/10.20147/COPD,S107307.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLB/WHO Workshop Report. Updated 2011. Available from: http: www.goldcopd.Acceed February 15, 2013.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Diaz-Guzman E., Mannino DM. Airway obstructive diseases in older from detection to treatment. J. Allergy Clin Immunol. 2010; 126: 702-709.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Barnes PJ. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. J. Allergy Clin Immunol. 2015; 136: 531-545.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Gerhardsson de Verder M., Andersson M., Kern DM, Zhou S., Tunceli O. Asthma and chronic obstructive pulmonary disease overlap syndrome doublet costs compared with patients with asthma alone. Value Health. 2015; 18: 759-766.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Gonzalez-Aguirre JE, Mercado-Longorio R. Asthma-COPD overlap syndrome: A work in progress. 2017. OAT. DOI: 10.15761/PCCM.100032.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Sin DD, Miravitless M., Mannino DM, Soriano JB, Price D., Celli BR et al. What is asthma - COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016; 48: 664-673.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Жигальцова-Кучинская ОА, Сивицкая ЛН, Данилен-ко НГ, Жигальцов АМ, Нагорнов ИВ и соавт. Дефицит альфа-1-антитрипсина: генетические основы, эпидемиология, значение в развитии бронхолегочной патологии. Вестник ВГМУ. 2015; (6): 39-52</mixed-citation></ref></ref-list></back></article>
